Thursday, August 28, 2025 7:36 AM ET
9 hours ago
FDA approves new Covid shots with limits on who can get them13 hours ago
Healthy Returns: Eli Lilly's Chief Scientific Officer talks obesity pill data18 hours ago
MAHA loves dietary supplements. But that hasn't led to gains in Washington — yet.1 day ago
Eli Lilly's weight loss pill clears its latest trial, paving way for approval2 days ago
A world on weight loss drugs: How GLP-1s are reshaping the economy2 days ago
Eli Lilly's obesity pill rivals Novo's oral Wegovy despite underwhelming data2 days ago
Supreme Court allows Trump's cuts to health research grants over DEI policies6 days ago
Microplastics are everywhere. Here's why that matters to big oil7 days ago
Epic touts new AI tools for patients and doctors at company's annual meeting8 days ago
FDA approves first-ever glucose monitoring system for weight loss from Signos8 days ago
Healthy Returns: Study casts doubts on RFK Jr.'s reasons for gutting vaccine panel8 days ago
Viking Therapeutics shares plunge on disappointing obesity pill trial data8 days ago
Novo Nordisk offers steep Ozempic discount for cash-paying U.S. patients8 days ago
Bill Gates meets Willy Wonka: How Epic's 82-year-old CEO built her software factory9 days ago
UnitedHealth shares log best day since 2020 after Buffett's new stake is revealed12 days ago
Nike co-founder Phil Knight to donate $2 billion to OHSU's Knight Cancer Institute13 days ago
Eli Lilly hikes price of Mounjaro in UK amid Trump pressure on pharma13 days ago
Apple Watch getting redesigned blood oxygen feature following legal dispute13 days ago
Healthy Returns: FDA launches program to boost U.S. drug manufacturing13 days ago
FDA may pull authorization of Pfizer's Covid vaccine for kids under 5, company says14 days ago
Omada Health beats on revenue in first earnings report since IPO20 days ago
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers20 days ago
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro sales soar20 days ago
Eli Lilly shares drop after obesity pill shows modest late-stage trial results20 days ago
Eli Lilly earnings are coming Thursday. Here's what top analysts expect21 days ago
Candy giant Mars partners with biotech firm to gene-edit cocoa supply21 days ago
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs21 days ago
Hinge Health stock pops 6% after first quarterly report since IPO22 days ago
Former X CEO Linda Yaccarino takes helm at digital health company eMed22 days ago
Trump says pharma tariffs could eventually reach up to 250%22 days ago
Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results23 days ago
Hims & Hers stock falls 10% on revenue miss23 days ago
Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.27 days ago